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Development of Electronic Health Record for
Chinese Medicine eHR(CM) Sharing System in
Hong Kong
Ruth LEUNG1, Kam Fung CHUNG1,
Veronica LI2, Rita CHEUNG2, Corey LAM2,
Eric ZIEA2
1 Chinese Medicine Department, Hospital
Authority
2 Chinese Medicine Department, Hong Kong
Hospital Authority
Purpose: Currently in Hong Kong, health-related and med-
ical data are usually created and kept by different healthcare
providers (or sometimes by individual patients) at differ-
ent locations in different formats, e.g. at CMP’s clinics and
herbalists shops.While somehealthcareprovidersmaydeploy
electronicmedical/patient record systems to store and retrieve
medic al/patient data, such systems are generally not capable
of data sharing at any large scale if at all. An eHR Sharing
System provides an information infrastructure for healthcare
providers in both the public and private healthcare sectors,
with informed and express consent of the patient and proper
authorisation for access to the System, to share the eHR they
keep on the patient with other healthcare providers and to
retrieve the eHR of the patient shared by other healthcare
providers.
Methods: During the ﬁrst stage of the project, standard-
isation of clinical terms mainly focused on four domains
including diseases ( ), patterns ( ), acupoints ( ) and
interventions ( ).
Results: The initial design and architecture of the Chi-
nese Medicine Clinical Terminology Table (CMCTT) has been
established. Common terms in relation to diseases, acupoints,
patterns and inventions were analysed and incorporated into
the CMCTT.
Conclusion: Standardisation of CM information forms the
basis for accurate and efﬁcient communication of electronic
CM data. It facilitates uniform communications and reduces
costs of technical integration. A proper management frame-
work on standard development lifecycle will ensure the
concepts are properly created, described and organised which
will enhance data accuracy and quality for health information
exchange. Both CM Terminology tables and the maintenance
process are essential to the development and daily operation
of terminology standard to support data sharing to the eHR.
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A Comparative study on Chinese Western
Medicine diagnoses and related outcomes for
different types of stroke
Rita CHEUNG, Kam Fung CHUNG,
Veronica LI, Ruth LEUNG, Corey LAM,
Eric ZIEA, Dora TSUI
Chinese Medicine Department, Hospital Authority
Purpose: In Hong Kong, stroke ranks third as themost com-
mon cause of death. Every year, there are more than 20,000
stroke patients admitted to Hospital Authority (HA) hospitals.
Facing this disabling disease, patients are actively looking for
concurrent treatments in both Chinese medicine (CM) and
Western medicine (WM). In accordance with the vision of the
Food and Health Bureau, this study aims to analyse signiﬁcant
inter-professional parameters and to facilitate the develop-
ment of IntegratedChinese-WesternMedicine (ICWM) inHong
Kong. The three main objectives of this study are: 1. To explore
the correlation between WM primary / secondary diagnostic
parameters and CM diagnosis in stroke; 2. To examine the
health seeking behaviors of stroke patients and the associa-
tion with stroke outcomes; and 3. To determine a combination
of CM and WM treatments that are most beneﬁcial to this
group of patients.
Methods: Clinical data of patients in the Stroke Registry
of a HA hospital will be extracted from the electronic medi-
cal records stored in the Clinical Management System (CMS).
For those patients who also had Chinese Medicine Consulta-
tions at the tripartite CM Centres for Training and Research
(CMCTRs), data will be extracted from the Chinese Medicine
Information System (CMIS).
Results: Data mining techniques will be applied to explore
diagnostic and treatment patterns of CM and WM. The result-
ing data network can help develop an understanding on the
linkage of health variables. A comprehensive analysis can
then be performed to comp are the outcomes of acute stroke
patients with or without seeking CM consultations, which
could elucidate any signiﬁcant favorable effects of treatments.
Conclusion: Through analysing the matched clinical
dataset, this study may shed light on the effectiveness of com-
bined treatments of CM and WM on stroke and bring insights
into the underlying factors that associate with speciﬁc stroke
outcomes.
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Challenges and opportunities for the Korean
ginseng industry: A plot survey of market
expansion among ginseng companies
Jong-Min Woo, Miyoung Ahn, Eun-Ji Park,
Soohyun Kwon, Ki Hoon Koo
Korea Institute of Oriental Medicine
Purpose: Ginseng products have been widely consumed as
dietary supplements across the globe. The ginseng industry
Integr Med Res ( 2 0 1 5 ) 42–144 116
is a promising business worldwide, and its globalization is a
governmental interest. This study aimed to investigate the
current state of the industry, including employment status
and manufacturing sources and to assess the factors asso-
ciated with the development of the ginseng industry and its
entry into the international market.
Methods: A company-based survey was conducted by
ginseng product manufacturers in South Korea. Eligible
companies (N=186) were randomly selected and were admin-
istered questionnaires.
Results: Most of the participants stated they were “produc-
tionworkers”. Among a variety of ginseng species, red ginseng
(hongsam) was utilized as the primary species (90.0%), fol-
lowed by wild ginseng (sansam), fresh ginseng (sansam), and
black ginseng (heuksam). Most respondents perceived “public
relations” as being a critical factor for the development of this
industry. “Low manpower” was the most substantial hurdle
for industrial growth. In total, 59.3% of respondents suggested
that “seeking business partners” was essential for obtaining
market globalization.
Conclusion: The companies that responded showed vary-
ing opinions in our survey. These results are useful for
designing proper marketing strategies and priorities, based on
a professional perspective.
Contact: Jong-Min Woo, jmwoo@kiom.re.kr
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Current R&D challenges for market
expansion of traditional Korean medicine: a
company-based survey in 2014
Miyoung Ahn, Eun-Ji Park, Dong su Kim,
Jong-Min Woo, Soohyun Kwon, Ki Hoon Koo
Korea Institute of Oriental Medicine
Purpose: The consumption of traditional Korean medicine
(TKM), a subset of Complementary and Alternative medicine
(CAM) has markedly increased. Accordingly, the TKM industry
has also expanded. TKM products are found in various mar-
kets, such as food, medicine, medical devices, and cosmetics;
however, product items are limited and their market shares
remain small. The purpose of this study is to investigate the
current R&D status of the TKM industry and predict the most
challengeable market in the future.
Methods:Acompany-based surveywasdesigned to explore
the readiness of market expansion and assess promising
industry among TKM workers. A validated survey instrument
was constructed and distributed to 400 TKM product manu-
facturing companies in South Korea in 2014 via e-mail or fax.
A 71.2% response rate was achieved.
Results: Of the participating companies, 61.1% were
equipped with research and development (R&D) facilities. The
ratio was highest in the companies that produced TKM cos-
metics (95%), and lowest in the companies that produced TKM
foods (44.7%). The average number of research workers was
8.3, and the highest number of workers was found in a com-
pany that manufactured ﬁnished-medicinal products (15.8).
In addition, 25.9% of the companies invested less than 5% of
their total budget into R&D. The dietary industry was the most
promising ﬁeld for future TKM market expansion (43.9%). The
demand for technical convergence was highest in both med-
ical companies and cosmetics companies (83.3% and 85.0%,
respectively).
Conclusion: Regarding manpower and installation, most
companies were capable of performing R&D activities. How-
ever,modest R&D investmentwas likely to be a limiting factor.
The dietary industry was perceived as being the most promis-
ing ﬁeld for future market expansion. This study explored the
current industrial status and future R&D demands in the TKM
industry.
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UK National Health Service clinical practice
guidelines mentioning complementary and
alternative medicine (CAM) – awareness of
CAM practitioners
Nicola Robinson, Ava Lorenc
London South Bank University
Purpose: To assess UK CAM practitioners’ awareness of
National Health Service (NHS) guidelines mentioning CAM,
their use and perceptions of their impact.
Methods: Phase 1 searched the UK NHS Evidence web-
site for guidelines mentioning CAM. Phases 2 and 3 were
online surveys about awareness and use of guidelines with
professional CAM organizations (phase 2) and individual CAM
practitioners (Phase 3).
Results: Phase 1: 43 of 279 guidelines reviewed (13%) men-
tioned CAM; 44% were inconclusive whether to recommend,
mainly due to lack of evidence. Phase 2: CAM professional
bodies identiﬁed 17 further guidelines. They appeared largely
unaware of guidelines mentioning their therapy but posi-
tive about guidelines’ potential to integrate CAM and keen
to facilitate communication regarding evidence for their ther-
apy. Phase 3: Of 865 respondents; 83% were female, half over
50, average 11 years in practice, main CAM practices were
massage, reﬂexology, reiki, aromatherapy, herbal medicine,
3% were NHS-employed, 20% medically trained. 47% felt
NHS guidelines were relevant for CAM – mainly to encour-
age integration and NHS referrals. 79% were unaware of
guidelines regarding their therapy. Most commonly cited
guidelines were back pain and irritable bowel. Practitioner
organisations and NHS websites were information sources
accessed. Guidelines were used to inform practice, maintain
standards and as evidence. Respondents suggested guide-
lines were needed for: stress, musculoskeletal conditions,
depression/anxiety, IBS, cancer and digestive disorders, and
evidence was needed for: pain, stress, cancer, and mental
health. Half were willing to engage with future guideline
development.
Conclusion: Despite recognising that clinical guidelines
can potentially facilitate CAM integration, practitioners and
regulatory bodies appeared largely unaware of CAM guid-
ance. Lack of CAM evidence for guideline development, areas
